NVZMY - Novozymes A/S

Other OTC - Other OTC Delayed Price. Currency in USD
53.88
+1.36 (+2.59%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close52.52
Open53.65
Bid0.00 x 0
Ask0.00 x 0
Day's Range53.29 - 54.01
52 Week Range37.73 - 57.84
Volume16,231
Avg. Volume23,832
Market Cap14.91B
Beta1.24
PE Ratio (TTM)30.79
EPS (TTM)1.75
Earnings DateN/A
Forward Dividend & Yield0.74 (1.49%)
Ex-Dividend Date2017-02-22
1y Target Est58.39
Trade prices are not sourced from all markets
  • Capital Cube4 months ago

    ETFs with exposure to Novozymes A/S : November 2, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Novozymes A/S Here are 5 ETFs with the largest exposure to NVZMY-US. Comparing the performance and risk of Novozymes A/S with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Reuters4 months ago

    Novozymes shares surge as bioenergy tops expectations

    Denmark's Novozymes reported third-quarter sales and earnings ahead of forecasts on Wednesday and raised its outlook as more powerful enzymes products drove demand from ethanol makers, sending its shares up six percent to a two-year high. Ethanol is made by using enzymes to break down and ferment sugars in organic materials, such as corn, but second generation ethanol, made from more stubborn cellulose using new processes, could raise production. Sales at Novozymes' bioenergy unit rose by 16 percent in the quarter compared to the less than three percent expected by analysts, as ethanol firms chose the new products and showed improved buying power, Sydbank analyst Morten Imsgard said.

  • Novozymes A/S :NVZMY-US: Earnings Analysis: Q2, 2017 By the Numbers : August 21, 2017
    Capital Cube6 months ago

    Novozymes A/S :NVZMY-US: Earnings Analysis: Q2, 2017 By the Numbers : August 21, 2017

    Categories: Yahoo FinanceGet free summary analysis Novozymes A/S reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Novozymes A/S – Innophos Holdings, Inc., Codexis, Inc., Procter & Gamble Company, E. I. du Pont de Nemours and Company and Syngenta AG Sponsored ADR (IPHS-US, CDXS-US, PG-US, DD-US ... Read more (Read more...)

  • Reuters6 months ago

    Novozymes shares fall as Q2 pressured by detergent makers, Monsanto alliance

    Danish enzymes maker Novozymes undershot market expectations in the second quarter pressured by cost cuts at detergent makers and a changed sales pattern in its cooperation with Monsanto. * Novozymes's second quarter result fell 2 percent to 735 million Danish crown ($116.3 million), below analysts expectations for a 2 percent rise. * The company lowered its guidance measured in Danish crowns, while maintaining it in local currencies.

  • Novozymes A/S :NVZMY-US: Earnings Analysis: Q1, 2017 By the Numbers : April 28, 2017
    Capital Cube10 months ago

    Novozymes A/S :NVZMY-US: Earnings Analysis: Q1, 2017 By the Numbers : April 28, 2017

    Categories: Yahoo FinanceGet free summary analysis Novozymes A/S reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Novozymes A/S – Procter & Gamble Company and E. I. du Pont de Nemours and Company (PG-US and DD-US) that have also reported for this period. Highlights Summary numbers: ... Read more (Read more...)